Blood · 2019 · 70 citations · 24 references
Life SciencesImmunologyInfectious DiseasesImmunopathologyMolecular VirologyVirologyAutoimmune DiseasesViral EpidemiologyViral InfectionsHydroa VacciniformeHydroa Vacciniforme-like Lymphoproliferative Disorder
Patients with classic hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) typically have high levels of Epstein-Barr virus (EBV) DNA in T cells and/or natural killer (NK) cells in blood and skin lesions induced by sun exposure that are infiltrated with EBV-infected lymphocytes. HVLPD is very rare in the United States and Europe but more common in Asia and South America. The disease can progress to a systemic form that may result in fatal lymphoma. We report our 11-year experience with 16 HVLPD patients from the United States and England and found that whites were less likely to develop systemic EBV disease (1/10) than nonwhites (5/6). All (10/10) of the white patients were generally in good health at last follow-up, while two-thirds (4/6) of the nonwhite patients required hematopoietic stem cell transplantation. Nonwhite patients had later age of onset of HVLPD than white patients (median age, 8 vs 5 years) and higher levels of EBV DNA (median, 1 515 000 vs 250 000 copies/ml) and more often had low numbers of NK cells (83% vs 50% of patients) and T-cell clones in the blood (83% vs 30% of patients). RNA-sequencing analysis of an HVLPD skin lesion in a white patient compared with his normal skin showed increased expression of interferon-γ and chemokines that attract T cells and NK cells. Thus, white patients with HVLPD were less likely to have systemic disease with EBV and had a much better prognosis than nonwhite patients. This trial was registered at www.clinicaltrials.gov as #NCT00369421 and #NCT00032513.
24
Fitzpatrick’s Dermatology in General Medicine
Heart & Lung · 1999 · 3.3K citations
Richard D. Wood, Michael Mitchell, John Sgouros et al. · Science · 2001 · 1.5K citations
Jeffrey I. Cohen, Hiroshi Kimura, Shigeo Nakamura et al. · Annals of Oncology · 2009 · 283 citations · Full text
Life Sciences, Immunology, Pathology +13